Immunoregulatory peptides and methods of use
First Claim
Patent Images
1. A pharmaceutical peptide composition comprising:
- a peptide, wherein the peptide comprises SEQ ID NO;
337; and
a pharmaceutically-acceptable excipient, wherein the pharmaceutical composition is in a unit dosage form.
1 Assignment
0 Petitions
Accused Products
Abstract
Peptides for the treatment of inflammation, and therapeutic uses and methods of using the same are disclosed. Peptides including a transducing sequence are effective for inhibiting cytokine activity and TNF-α secretion through interaction with toll-like receptors. Experiments are described illustrating the efficacy of the compounds in treating otitis media
36 Citations
8 Claims
-
1. A pharmaceutical peptide composition comprising:
- a peptide, wherein the peptide comprises SEQ ID NO;
337; and
a pharmaceutically-acceptable excipient, wherein the pharmaceutical composition is in a unit dosage form. - View Dependent Claims (2, 3, 4, 5)
- a peptide, wherein the peptide comprises SEQ ID NO;
-
6. A synthetic peptide of SEQ ID NO:
- 337, wherein at least one amino acid residue of the synthetic peptide is in the D-configuration.
- 7. A synthetic peptide comprising SEQ ID NO:
Specification